Beam Therapeuticsの浮動株式数
Beam Therapeuticsの浮動株式数は何ですか。
Beam Therapeutics Inc.の浮動株式数は54.087M 79.38%です。
浮動株式数の定義は何ですか。
浮動株式数は、ロックインされた株式とは対照的に、公的投資家の手にある企業の株式の一部です。
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
NASDAQのセクタHealth Careにおける浮動株式数の企業と比べるBeam Therapeutics
Beam Therapeuticsは何をしますか。
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Beam Therapeuticsと類似の浮動株式数
- ASOS Plcの浮動株式数は53.982M 54.01%です。
- ASOS Plcの浮動株式数は53.982M 54.01%です。
- Sino Gasの浮動株式数は54.000M 25.00%です。
- TAO Commoditiesの浮動株式数は54.001M 172.05%です。
- India Steel Worksの浮動株式数は54.008M 13.57%です。
- Computer And Technologiesの浮動株式数は54.062M 21.67%です。
- Beam Therapeuticsの浮動株式数は54.087M 79.38%です。
- Whirlpoolの浮動株式数は54.090M 89.05%です。
- Whirlpoolの浮動株式数は54.090M 84.77%です。
- Majestic Wine Plcの浮動株式数は54.092M 73.66%です。
- Cache Explorationの浮動株式数は54.099M 104.77%です。
- Petrox Resourcesの浮動株式数は54.111M 98.15%です。
- CannPal Animal Therapeuticsの浮動株式数は54.118M 58.11%です。